Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

Q1 2014 13F Holders as of 3/31/2014

Type / Class: Equity / COMMON STOCK
Shares outstanding: 96M
Number of holders: 76
Total 13F shares, excl. options: 15.3M
Shares change: +15.3M
Total reported value, excl. options: $730M
Value change: +$730M
Number of buys: 75
Price: $48.89

Significant Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2014

76 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q1 2014.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.3M shares of 96M outstanding shares and own 15.98% of the company stock.
Largest 10 shareholders include TPG Group Holdings (SBS) Advisors, Inc. (3.09M shares), Capital Research Global Investors (2.06M shares), ADAGE CAPITAL PARTNERS GP LLC (1.84M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.39M shares), WELLINGTON MANAGEMENT CO LLP (632K shares), Visium Asset Management, LP (455K shares), Capital World Investors (362K shares), JENNISON ASSOCIATES LLC (283K shares), and ALLIANCEBERNSTEIN L.P. (247K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.